As artificial intelligence (AI) advances, it’s poised to revolutionize surgery, offering accuracy surpassing human abilities and potentially transforming healthcare as we know it. A recent study published in June at Oxford Academic showed that leading AI models exhibit remarkable diagnostic accuracy in diverse clinical cases. This technology holds promise for more precise diagnoses, affordable procedures, reduced errors, and consistent treatment outcomes. 1. Accuray Inc. (NASDAQ: ARAY): Accuray’s focus on non-invasive robotic surgery using stereotactic radiosurgery (SRS) is a prime example of this potential. Accuray’s systems offer sub-millimeter precision for delicate procedures like brain and spine surgeries, with over 350 units deployed worldwide. The company recently reported $127.5 million in revenue ending June 2025, showcasing their growth potential despite a slight year-over-year decrease. 2. Siemens Healthineers AG (OTC: SMMNY): This subsidiary of Siemens focuses on medical and molecular imaging with its extensive robotic capabilities and pioneering AI advancements. The company is particularly focused on endovascular robotics, poised to revolutionize strokes treatment. Their success in developing advanced AI-powered imaging solutions positions them well for a future dominated by AI-driven healthcare. 3. Intuitive Surgical Inc. (NASDAQ: ISRG): This industry leader has been at the forefront of robotic-assisted minimally invasive surgery for years. Their systems provide both recurring revenue through consumables and long-term contracts, while extensive use of AI in real-time precision and early cancer detection continues to drive their success. 3. These companies offer a glimpse into the future of medical technology as it becomes more personalized, precise, and accessible thanks to the power of AI.